146 related articles for article (PubMed ID: 2479707)
1. CD19 is functionally and physically associated with surface immunoglobulin.
Pesando JM; Bouchard LS; McMaster BE
J Exp Med; 1989 Dec; 170(6):2159-64. PubMed ID: 2479707
[TBL] [Abstract][Full Text] [Related]
2. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
4. Co-crosslinking Fc epsilon RII/CD23 and B cell surface immunoglobulin modulates B cell activation.
Campbell KA; Lees A; Finkelman FD; Conrad DH
Eur J Immunol; 1992 Aug; 22(8):2107-12. PubMed ID: 1386315
[TBL] [Abstract][Full Text] [Related]
5. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.
Wheeler K; Pound JD; Gordon J; Jefferis R
Eur J Immunol; 1993 May; 23(5):1165-8. PubMed ID: 7682959
[TBL] [Abstract][Full Text] [Related]
6. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
7. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of CD19 in pre-B and mature B cells.
Chalupny NJ; Kanner SB; Schieven GL; Wee SF; Gilliland LK; Aruffo A; Ledbetter JA
EMBO J; 1993 Jul; 12(7):2691-6. PubMed ID: 7687539
[TBL] [Abstract][Full Text] [Related]
9. Properties of mouse CD40. Ligation of CD40 activates B cells via a Ca(++)-dependent, FK506-sensitive pathway.
Klaus GG; Choi MS; Holman M
Eur J Immunol; 1994 Dec; 24(12):3229-32. PubMed ID: 7528676
[TBL] [Abstract][Full Text] [Related]
10. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-beta, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis.
Holder MJ; Knox K; Gordon J
Eur J Immunol; 1992 Oct; 22(10):2725-8. PubMed ID: 1382997
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
Kansas GS; Tedder TF
J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
[TBL] [Abstract][Full Text] [Related]
12. Immature surface Ig+ B cells can continue to rearrange kappa and lambda L chain gene loci.
Rolink A; Grawunder U; Haasner D; Strasser A; Melchers F
J Exp Med; 1993 Oct; 178(4):1263-70. PubMed ID: 8376934
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2-dependent induction of B cell unresponsiveness. Role of surface Ig and Fc receptors.
Schad V; Phipps RP
J Immunol; 1989 Oct; 143(7):2127-32. PubMed ID: 2506277
[TBL] [Abstract][Full Text] [Related]
14. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
Matsumoto AK; Kopicky-Burd J; Carter RH; Tuveson DA; Tedder TF; Fearon DT
J Exp Med; 1991 Jan; 173(1):55-64. PubMed ID: 1702139
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin-specific T-B cell interaction. IV. B cell presentation of idiotypic determinant(s) of monoclonal anti-surface immunoglobulin antibody to idiotope-recognizing helper T clones.
Rudensky AY; Mazel SM; Blechman JM; Yurin VL
Eur J Immunol; 1990 Aug; 20(8):1691-6. PubMed ID: 2120062
[TBL] [Abstract][Full Text] [Related]
16. Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95.
Rijkers GT; Griffioen AW; Zegers BJ; Cambier JC
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8766-70. PubMed ID: 1701054
[TBL] [Abstract][Full Text] [Related]
17. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
18. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
19. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
20. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
